LifeSciVC

MAY 14, 2025

1,2,3 Among a long list of innovations, the lowest hanging fruit for commercialization is the use of microgravity-based crystallization to enhance high-value pharmaceuticals. Microgravity crystallization, in combination with modern innovations in antibody engineering (e.g., half-life extension) and formulation / delivery (e.g.,

Science

Drug Target Review

OCTOBER 30, 2024

Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. He has over 20 years’ experience in biomedical research and pharmaceutical drug discovery. Schizophrenia risk from complex variation of complement component 4. 2016;530(7589):177-83. 2017;23(1):49-59. 2019;363(6423):126-7.

Treatment

The Pharma Data

JUNE 25, 2025

Salanersen was engineered as an advanced ASO therapeutic, building on Biogen’s experience with SPINRAZA. Strategic Collaboration with Ionis Pharmaceuticals Salanersen originated from Biogen’s longstanding collaboration with Ionis Pharmaceuticals, Inc. , a leader in RNA-targeted therapeutics.

Therapies

The Pharma Data

JUNE 22, 2025

Engineered by Chugai Pharmaceutical Co., However, NXT007 takes the science a step further with refined molecular engineering aimed at achieving enhanced efficacy, longer dosing intervals, and a more predictable bleeding protection profile.

Clinical Trials

The Pharma Data

JULY 2, 2025

HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the official launch of WuXiHigh™ 2.0 , a next-generation, high-throughput formulation development platform specifically engineered for high-concentration biologics. WuXi Biologics Launches WuXiHigh™ 2.0

FDA Approval

The Pharma Data

JUNE 18, 2025

A Next-Generation Antibody-Drug Conjugate Targeting B7-H3 Ifinatamab deruxtecan is a potential first-in-class antibody-drug conjugate (ADC) specifically engineered to target B7-H3 , a surface protein overexpressed in many solid tumors, including prostate cancer.

Trials

Drug Target Review

JUNE 2, 2025

His journey began in the early stages of his career, initially working with small molecules as a chemical engineer in development and manufacturing. This partnership blends Lonzas manufacturing expertise with BigHats machine-learning platform for antibody engineering. BigHat is a very interesting company.

Small Molecule

The Pharma Data

JUNE 18, 2025

Alnylam Elevates Dr. Pushkal Garg to Lead Unified Research and Development Organization, Signaling Strategic Expansion into Next Phase of RNAi Therapeutics Innovation Alnylam Pharmaceuticals , a global leader in RNA interference (RNAi) therapeutics, has announced the promotion of Pushkal Garg, M.D.,

RNA

Drug Target Review

DECEMBER 9, 2024

Its applications include studying disease pathology to develop targeted therapeutics, visualising enzymes that can decompose plastics, and engineering solutions to antibiotic resistance, among many others. Further, trade secrets offer no protection against independent discovery or reverse engineering by competitors.

Engineering

Drug Target Review

DECEMBER 16, 2024

At the time, in India, we typically had two major career choices, engineering or medicine. With artificial intelligence, the pace of change is exciting for STEM, whether in medicine, engineering, space, or technology. I opted for medicine due to my love for biological sciences.

Medical Schools

Broad Institute

MAY 21, 2025

The idea of genetically instructing T cells to specifically eliminate cancer cells was born in the 1980s, but it would take 20 years to bring it to patients, said Sadelain, who left MSKCC last year to become the Herbert and Florence Irving Professor of Medicine and director of the Columbia Initiative in Cell Engineering and Therapy.

Therapies

The Pharma Data

JUNE 20, 2025

Beyond the clear clinical benefits demonstrated thus far, zimislecel represents a broader shift in the therapeutic landscape — one that leverages regenerative medicine, cellular engineering, and stem cell science to solve previously intractable medical challenges.

Therapies

SugarCone Biotech

JUNE 19, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. These are the patient’s own T cells that are engineered to express a binder to directly attack DLL3-positive cells.

Therapies

Alta Sciences

NOVEMBER 4, 2024

Case Study: How to Ensure Safety While Manufacturing Highly Potent APIs aasimakopoulos Mon, 11/04/2024 - 17:37 Highly potent active pharmaceutical ingredients (API) require careful attention to safety and handling during formulation and manufacturing. Are you working on a highly potent API? Contact us today to get your program on track.

Engineering

Drug Patent Watch

MARCH 3, 2025

Unlock the Power of Google Patents for Drug Patent Research As a researcher or professional in the pharmaceutical industry, staying on top of the latest developments in drug patents is crucial for making informed decisions. But with the vast amount of information available, it can be overwhelming to know where to start.

Research

ACTO

JULY 23, 2025

CxZone is built on ACTO’s proprietary Empathetic AI engine, which makes the AI-simulated HCP interaction realistic and personal. Built to improve customer experience (CX), CxZone helps field teams master clinical conversations in a fast, flexible, and feedback-rich environment tailored to the unique nuances of the industry. “It

Science

The Pharma Data

JUNE 24, 2025

Rather than diluting ownership or yielding developmental control to a larger pharmaceutical partner, Revolution Medicines is leveraging this funding arrangement to maintain autonomy over its research, development, and eventual commercialization efforts.

Clinical Development

Alta Sciences

JULY 23, 2025

Following the completion of a Doctor of Philosophy in Pharmaceutical Sciences from the Université de Montréal, and several years in the CRO industry, he has developed extensive expertise in flow cytometry technologies. The event proved to be a dynamic reflection of the current flow cytometry landscape.

International

Drug Target Review

JUNE 14, 2025

I began developing my own scripts to streamline processes, which led me into scientific informatics, where I worked with pharmaceutical companies on cheminformatics. The others were data scientists or software engineers from the informatics side, who were approaching data science and AI from a different angle.

Laboratories

Codon

NOVEMBER 3, 2024

Based on these results, Waksman asked the pharmaceutical company Merck to mass-produce streptomycin for further tests that could provide clearer evidence of its efficacy and safety. Testing the engineered cells against four common drugs, I found that the M. By inserting the gene into a harmless, related species called M.

Vaccine

The Pharma Data

JUNE 26, 2025

These elements collectively reduce the site’s ecological footprint while creating a healthier and more inspiring workplace for scientists, engineers, and support teams. Environmental consciousness is further evident in the facility’s energy-efficient systems, water conservation technologies, and waste management practices.

Laboratories

Drug Target Review

JUNE 5, 2025

5,6 The 2023 approval of two engineered stem cell-based therapies marked a significant advancement, though these options require careful consideration of potential adverse events and long-term safety, 7 and access will remain a challenge for the foreseeable future. Use of Disease-Modifying Treatments in Patients with Sickle Cell Disease.

Disease

Drug Target Review

NOVEMBER 7, 2024

These antibodies are engineered to bind to specific cell-surface receptors in a multivalent manner, effectively cross-linking and clustering receptor complexes upon binding. Before Bayer, Judy held the role of Vice President of Pharmaceutical Operations at Pfizer, Inc./Medivation a clinical-stage biotech company in San Francisco, CA.

Disease

Codon

JANUARY 5, 2025

Oncley, a University of Wisconsin PhD, was not dissimilar to other Midwestern PhDs at the time; he was as much an instrumentalist, or a lab-instrument engineer, as a scientific researcher. These runs only yielded about two or three single-serve vials of albumin. And that was just the start. Cohn was rapidly learning.

Laboratories

LifeSciVC

JUNE 12, 2025

We intended to learn from nature (genetics) and use pharmaceuticals properties to drive patient benefit. As I wore my engineering hat, the most prudent way was to modify one variable at a time, and control known variables.

RNA

The Premier Consulting Blog

DECEMBER 16, 2024

Pharmaceutical companies may, at times, find themselves at an impasse during development, facing weighty decisions about whether to slow down or hit the brakes on a development program. GEN – Genetic Engineering and Biotechnology News. References: [i] Philippidis, A. 2023, February 28).

Pharmacokinetics

Drug Patent Watch

JULY 10, 2025

"The Secret to Unsealing Generic Drug Innovation: How Precision and Reproducibility Are Revolutionizing the Industry As the pharmaceutical landscape continues to shift towards more affordable and accessible treatments, the role of generic drug reverse engineering has never been more crucial.

Engineering

Advarra

MARCH 6, 2025

The Value of Clinical Research Clinical research is the engine that drives medical innovation, leading to the discovery of new drugs, treatments and medical devices that enhance patients access to treatment options, improve patient care and outcomes, and transform the healthcare landscape.

Clinical Research

BMG Labtech

JULY 10, 2025

1,2 rFC is a genetically engineered protein that is activated by endotoxin and is usually based on a fluorescent readout. Once activated, the rFC enzyme releases a fluorescently labeled product from an engineered substrate that is quantifiable and proportional to the amount of endotoxin present.

Animal Testing

Codon

JULY 14, 2025

My goal is not only to tell the story of a pharmaceutical staple but to share what my decades-long work in evidence synthesis in epidemiology has taught me about researching scientific history. This version of events was first reported in a footnote in a 1934 book on the history of chemical engineering.

Treatment

Drug Patent Watch

MAY 26, 2025

With a market share of over 25% of the global pharmaceutical industry, the Swiss pharma sector is a powerhouse to be reckoned with. Is it the country's reputation for precision engineering, its stunning natural beauty, or perhaps its rich chocolate heritage? But what drives this success? The answer may surprise you.

Engineering

Codon

JULY 10, 2025

Falling out of fashion with the rise of the modern pharmaceutical industry, it’s ready for a comeback driven not by mania, but rather by a mechanistic understanding of the molecules and bioactive compounds responsible for its efficacy. Still, despite this enthusiasm and the handful of successes, tree engineering remains challenging.

Engineering

Perficient: Drug Development

JUNE 3, 2025

Were proud to be recognized in the Forrester AI Technical Services Landscape as a consultancy with an industry focus in the sectors of financial services, manufacturing, and pharmaceuticals and medical equipment, and a geographic focus in North America, Asia Pacific, and Latin America.

Government

Drug Discovery Today

AUGUST 31, 2020

CPI has announced (27th August) the signing of partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines Manufacturing Innovation Centre collaboration.

Engineering

Nvidia Developer: Drug Discovery

OCTOBER 23, 2024

Pharmaceutical research demands fast, efficient simulations to predict how molecules interact, speeding up drug discovery. Pharmaceutical research demands fast, efficient simulations to predict how molecules interact, speeding up drug discovery. Jiqun Tu, a senior developer. In this NVIDIA GTC 2024 session… Source

Engineering

Drug Target Review

JUNE 27, 2023

As we delve into an exclusive article with Dr Haley Marks, biomedical engineer, and project scientist at CNSI in UCLA, and her exceptional team. In this eBook, embark on an exploration of how cutting-edge imaging modalities can elevate your biomedical research.

Engineering

The Pharma Data

MAY 19, 2023

HIGH SCHOOL SCIENTISTS AND ENGINEERS WIN NEARLY $9 MILLION AT THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR 2023 Regeneron Pharmaceuticals, Inc. ” Regeneron ISEF provides a global stage for the best and brightest young scientists and engineers around the world.

Engineering